Loading
Emergency physician who became Chief Executive of NICE, the body that appraises new cancer medicines and issues clinical guidance for the NHS, in December 2025.
Professor Jonathan Benger is Chief Executive of the National Institute for Health and Care Excellence (NICE), the English body that produces clinical guidelines and appraises the cost effectiveness of new treatments, including cancer drugs. He joined NICE in January 2023 as Chief Medical Officer, became interim director of the centre for guidelines in March 2023, was appointed deputy chief executive in May 2024 and chief executive in December 2025. Earlier he was interim chief clinical information officer at NHS England, Chief Medical Officer of NHS Digital and national clinical director for urgent and emergency care.
These papers come from a Europe PMC search on the author's name and institution, taking the most cited articles.
Shares Health technology assessment (HTA), reimbursement and QALYs and the tags leadership, clinician-scientist.
Shares Health technology assessment (HTA), reimbursement and QALYs and the tag leadership.
Shares Health technology assessment (HTA), reimbursement and QALYs, National Institute for Health and Care Excellence.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.